![Pfizer to Buy Medivation for $14 Billion, But Who Are the Real Winners?](https://evolution-bio.com/wp-content/uploads/2016/08/160822-pfizer-medivation-bio.jpg)
Pharmaceutical giants Pfizer are expanding their cancer portfolio through the $14B acquisition of California-based biopharmaceutical company Medivation. The acquisition follows two recent unsuccessful bids for Medivation by Sanofi, as well
![Evolution Infographic: The Rise & Diversification of Biologics](https://evolution-bio.com/wp-content/uploads/2016/02/160223-biologics-featured.jpg)
For our latest Data Visualisation project, the Evolution Global Team analysed historical new drug approval statistics and the current clinical trials pipeline to identify trends that highlight the rise and